ARTICLE | Clinical News
Heparin regulatory update
March 24, 2008 7:00 AM UTC
Baxter and FDA said they have identified the contaminant found in the active pharmaceutical ingredient (API) used in the company's heparin vial products. The contaminant is hypersulfated chondroitin s...